The Salvador–Warts–Hippo pathway — an emerging tumour-suppressor network
The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Abstract
Intense research over the past four years has led to the discovery and characterization of a novel signalling network, known as the Salvador-Warts-Hippo (SWH) pathway, involved in tissue growth control in Drosophila melanogaster. At present, eleven proteins have been implicated as members of this pathway, and several downstream effector genes have been characterized. The importance of this pathway is emphasized by its evolutionary conservation, and by increasing evidence that its deregulation occurs in human tumours. Here, we review the main findings from Drosophila and the implications that these have for tumorigenesis in mammals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Brennecke, J., Hipfner, D. R., Stark, A., Russell, R. B., & Cohen, S. M. (2003) · Cell · doi:10.1016/s0092-8674(03)00231-9 · Cited by 2,042
Huang, J., Wu, S., Barrera, J., Matthews, K., & Pan, D. (2005) · Cell · doi:10.1016/j.cell.2005.06.007 · Cited by 1,863
A Protein Interaction Map of Drosophila melanogaster
Giot, L., Bader, J. S., Brouwer, C., Chaudhuri, A., Kuang, B., Li, Y., Hao, Y. L., Ooi, C. E., Godwin, B., Vitols, E., et al. (2003) · Science · doi:10.1126/science.1090289 · Cited by 1,863 · cited 1×
“In unbiased protein–protein interaction screens in both Drosophila and mammals, YKI and YAP, and SD and TEF proteins were identified as binding partner”
BackgroundERM proteins and merlin: integrators at the cell cortex
Bretscher, A., Edwards, K., & Fehon, R. G. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm882 · Cited by 1,306
A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumors
Voorhoeve, P. M., le Sage, C., Schrier, M., Gillis, A. J. M., Stoop, H., Nagel, R., Liu, Y.-P., van Duijse, J., Drost, J., Griekspoor, A., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.037 · Cited by 1,264
Wu, S., Huang, J., Dong, J., & Pan, D. (2003) · Cell · doi:10.1016/s0092-8674(03)00549-x · Cited by 1,098
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S.-T., Luk, J. M., Wigler, M., Hannon, G. J., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.030 · Cited by 1,065
Dammann, R., Li, C., Yoon, J.-H., Chin, P. L., Bates, S., & Pfeifer, G. P. (2000) · Nature Genetics · doi:10.1038/77083 · Cited by 1,064
Justice, R. W., Zilian, O., Woods, D. F., Noll, M., & Bryant, P. J. (1995) · Genes & Development · doi:10.1101/gad.9.5.534 · Cited by 977
Research works printed but not linked: 1
- Polesello, C., Huelsmann, S., Brown, N. H. & Tapon, N. The Drosophila RASSF homologue antagnosis the Hippo pathway. Curr. Biol. 16, 2459–2465 (2006). · DOI · Paper page
Cited by
Items 101–200 of 629
Modeling Human Cancers in Drosophila
Sonoshita, M., & Cagan, R. L. (2016) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.07.008 · Cited by 153
“The Hippo pathway has been implicated in cancer development because it controls cell proliferation, cell fate, and organ size (Halder & Johnson, 2011; Hariharan, 2015; Harvey & Tapon, 2007).”
BackgroundCell Junctions in Hippo Signaling
Karaman, R., & Halder, G. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028753 · Cited by 138
Yap1 Protein Regulates Vascular Smooth Muscle Cell Phenotypic Switch by Interaction with Myocardin
Xie, C., Guo, Y., Zhu, T., Zhang, J., Ma, P. X., & Chen, Y. E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.329268 · Cited by 134
JNK phosphorylates Yes-associated protein (YAP) to regulate apoptosis
Tomlinson, V, Gudmundsdottir, K., Luong, P., Leung, K.-Y., Knebel, A., & Basu, S. (2010) · Cell Death & Disease · doi:10.1038/cddis.2010.7 · Cited by 131
“In contrast to regulating apoptosis by activation of p73, the growth control role of YAP or its fly homolog, Yorkie (Yki), is due to inactivation by the MST2 (HIPPO in fly) pathway.(16,17) Here, the tumor-suppressor LATS1 kinase (WTS in fly) directly phosphorylates YAP (Yki), inhibiting its co-activation of the TEAD (…”
BackgroundItch E3 ubiquitin ligase regulates large tumor suppressor 1 stability
Ho, K. C., Zhou, Z., She, Y.-M., Chun, A., Cyr, T. D., & Yang, X. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101273108 · Cited by 134
NDR Functions as a Physiological YAP1 Kinase in the Intestinal Epithelium
Zhang, L., Tang, F., Terracciano, L., Hynx, D., Kohler, R. S., Bichet, S., Heß, D., Cron, P. D., Hemmings, B. A., Hergovich, A., et al. (2015) · Current Biology · doi:10.1016/j.cub.2014.11.054 · Cited by 141
“Originally delineated in flies, the Hippo kinase phosphorylates the Lats/Warts kinase, which in turn restricts Yorkie *Correspondence: a.hergovich@ucl.ac.uk (A.H.), debora.schmitz@fmi.ch (D.S.-R.) activity by phosphorylating serine 168 (S168) [2].”
BackgroundSAV1 promotes Hippo kinase activation through antagonizing the PP2A phosphatase STRIPAK
Bae, S. J., Ni, L., Osinski, A., Tomchick, D. R., Brautigam, C. A., & Luo, X. (2017) · eLife · doi:10.7554/elife.30278 · Cited by 132
“Through restricting cell proliferation and promoting apoptosis, the evolutionarily conserved Hippo pathway is critical for tissue homeostasis and tumor suppression (Harvey and Tapon, 2007; Johnson and Halder, 2014; Pan, 2010; Yu et al., 2015).”
BackgroundPolesello, C., & Tapon, N. (2007) · Current Biology · doi:10.1016/j.cub.2007.09.049 · Cited by 131
“The Salvador Warts Hippo (SWH) network limits tissue size in Drosophila and vertebrates [1].”
InfluentialSelf-citationPremetazoan Origin of the Hippo Signaling Pathway
Sebé-Pedrós, A., Zheng, Y., Ruiz-Trillo, I., & Pan, D. (2012) · Cell Reports · doi:10.1016/j.celrep.2011.11.004 · Cited by 138
“…regulator of imaginal disc growth, and more recent studies have implicated a conserved function of this pathway in organ-size control in mammals (Zhao et al., 2010; Pan, 2010; Halder and Johnson, 2011; Zeng and Hong, 2008; Harvey and Tapon, 2007; Reddy and Irvine, 2008; Badouel et al., 2009).”
Biosignaling of mammalian Ste20-related kinases
Ling, P., Lu, T., Yuan, C.-J., & Lai, M.-D. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2007.12.019 · Cited by 137
Mitotic Exit and Separation of Mother and Daughter Cells
Weiss, E. L. (2012) · Genetics · doi:10.1534/genetics.112.145516 · Cited by 130
“These pathways have been labeled Mst/hippo or Ndr/LATS signaling systems, after mammalian and Drosophila kinases involved (Edgar 2006; Harvey and Tapon 2007; Hergovich 2011, 2012; Hergovich and Hemmings 2009; Varelas and Wrana 2012).”
BackgroundSun, C., De Mello, V., Mohamed, A., Ortuste Quiroga, H. P., Garcia-Munoz, A., Al Bloshi, A., Tremblay, A. M., von Kriegsheim, A., Collie-Duguid, E., Vargesson, N., et al. (2017) · Stem Cells · doi:10.1002/stem.2652 · Cited by 125
Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus
Li, W., Cooper, J., Karajannis, M. A., & Giancotti, F. G. (2012) · EMBO reports · doi:10.1038/embor.2012.11 · Cited by 130
“In agreement with this model, genetic analysis in Drosophila and mice showed that this pathway restrains cell proliferation and promotes apoptosis to limit organ size and suppress tumorigenesis &lsq”
MethodDu, L., Li, C., Qian, X., Yibing, C., Wang, L., Yang, H., Li, X., Li, Y., Xiaoxing, Y., & Lü, Q. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104320 · Cited by 131
KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals
Moleirinho, S., Chang, N., Sims, A. H., Tilston-Lünel, A., Angus, L., Steele, A., Boswell, V., Barnett, S. C., Ormandy, C. J., Faratian, D., et al. (2012) · Oncogene · doi:10.1038/onc.2012.196 · Cited by 137
The Salvador/Warts/Hippo pathway controls regenerative tissue growth in Drosophila melanogaster
Grusche, F., Degoutin, J. L., Richardson, H. E., & Harvey, K. F. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2010.11.020 · Cited by 132
“Defective SWH pathway signaling has been associated with a loss of tissue growth control in cancer (Harvey and Tapon, 2007).”
BackgroundInfluentialSelf-citationMst1 regulates integrin-dependent thymocyte trafficking and antigen recognition in the thymus
Ueda, Y., Katagiri, K., Tomiyama, T., Yasuda, K., Habiro, K., Katakai, T., Ikehara, S., Matsumoto, M., & Kinashi, T. (2012) · Nature Communications · doi:10.1038/ncomms2105 · Cited by 132
A kinase shRNA screen links LATS2 and the pRB tumor suppressor
Tschöp, K., Conery, A. R., Litovchick, L., DeCaprio, J. A., Settleman, J., Harlow, E., & Dyson, N. (2011) · Genes & Development · doi:10.1101/gad.2000211 · Cited by 125
“LATS2 is part of a well-studied tumor suppressor pathway (the Hippo pathway) that was first discovered in Drosophila (Edgar 2006; Harvey and Tapon 2007).”
BackgroundDeregulation of cell signaling in cancer
Giancotti, F. G. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.02.005 · Cited by 150
“Since CRL4DCAF1 induces a tumor suppressive gene expression program that includes the repression of a large fraction of YAP target genes [30], it seems likely that Merlin regulates YAP as well as other target genes through CRL4DCAF1.”
BackgroundInfluentialStructures of YAP protein domains reveal promising targets for development of new cancer drugs
Sudol, M., Shields, D. C., & Farooq, A. (2012) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2012.05.002 · Cited by 122
“As mentioned in previous chapters of this issue, the Hippo tumor suppressor pathway was originally delineated in Drosophila by genetic screening approaches [7].”
BackgroundYAP/TAZ for cancer therapy: Opportunities and challenges (Review)
Guo, L., & Teng, L. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2877 · Cited by 132
“The Hippo signal pathway was first discovered by mosaic genetic screens on Drosophila for mutants exhibiting tissue overgrowth in the 90s (1,2).”
BackgroundGenome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin
Alakus, H., Babicky, M. L., Ghosh, P., Yost, S. E., Jepsen, K., Dai, Y. D., Arias, A. D., Samuels, M. L., Mose, E. S., Schwab, R. B., et al. (2014) · Genome Medicine · doi:10.1186/gm559 · Cited by 121
“Hippo pathway inactivation has been observed in cancer [29] including CRC in which both FAT4 and FAT2 , putative Hippo pathway receptors [30], are significantly mutated in 24% of the cases [15].”
Hippo Pathway–Dependent and –Independent Roles of RASSF6
Ikeda, M., Kawata, A., Nishikawa, M., Tateishi, Y., Yamaguchi, M., Nakagawa, K., Hirabayashi, S., Bao, Y., Hidaka, S., Hirata, Y., et al. (2009) · Science Signaling · doi:10.1126/scisignal.2000300 · Cited by 120
Doggett, K., Grusche, F. A., Richardson, H. E., & Brumby, A. M. (2011) · BMC Developmental Biology · doi:10.1186/1471-213x-11-57 · Cited by 119
MARK4 inhibits Hippo signaling to promote proliferation and migration of breast cancer cells
Arash, E. H., Shiban, A., Song, S., & Attisano, L. (2017) · EMBO Reports · doi:10.15252/embr.201642455 · Cited by 123
“Given the growth promoting effects of YAP/TAZ, disruptions of YAP/TAZ activity are commonly associated with pathological conditions, especially cancer [3,8,23,24].”
Altered Hippo signalling in polycystic kidney disease
Happé, H., van der Wal, A. M., Leonhard, W. N., Kunnen, S. J., Breuning, M. H., de Heer, E., & Peters, D. J. (2011) · The Journal of Pathology · doi:10.1002/path.2856 · Cited by 121
“Besides regulating the Hippo pathway, Fjx1 is also thought to be a transcriptional target of YAP [18,33,34].”
BackgroundRegulation of the Hippo pathway and implications for anticancer drug development
Park, H. W., & Guan, K.-L. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.08.006 · Cited by 116
Liu, J.-Y., Li, Y.-H., Lin, H.-X., Liao, Y.-J., Mai, S.-J., Liu, Z.-W., Zhang, Z.-L., Jiang, L.-J., Zhang, J.-X., Kung, H.-F., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-349 · Cited by 116
“Yes-associated protein 1 (YAP 1), a 65-kDa proline-rich phosphorprotein, is one of the transcription co-activator which is regulated by the Hippo tumor suppressor pathway [4-8].”
BackgroundGuo, C., Zhang, X., & Pfeifer, G. P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.178210 · Cited by 117
WWC proteins mediate LATS1/2 activation by Hippo kinases and imply a tumor suppression strategy
Qi, S., Zhu, Y., Liu, X., Li, P., Wang, Y., Zeng, Y. J., Yu, A., Wang, Y., Sha, Z., Zhong, Z., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.03.027 · Cited by 125
The Hippo Pathway Regulates Neuroblasts and Brain Size in Drosophila melanogaster
Poon, C. L. C., Mitchell, K. A., Kondo, S., Cheng, L. Y., & Harvey, K. F. (2016) · Current Biology · doi:10.1016/j.cub.2016.02.009 · Cited by 122
Self-citationQu, L., Wu, Z., Li, Y., Xu, Z., Liu, B., Liu, F., Bao, Y., Wu, D., Liu, J., Wang, A., et al. (2016) · Nature Communications · doi:10.1038/ncomms12692 · Cited by 112
“The disruption of Hippo pathway can lead to tumorigenesis 47 .”
Targeting IRF3 as a YAP agonist therapy against gastric cancer
Jiao, S., Guan, J., Chen, M., Wang, W., Li, C., Wang, Y., Cheng, Y., & Zhou, Z. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20171116 · Cited by 117
“For example, the evolutionarily conserved Hippo and Wnt pathways are both frequently disturbed in gastrointestinal carcinoma (Pan, 2010; Deitrick and Pruitt, 2016; Hong et al., 2016; Bahrami et al., 2017).”
BackgroundDYRK1A: the double-edged kinase as a protagonist in cell growth and tumorigenesis
Fernández, P., Zahonero, C., & Gómez, P. S. (2015) · Molecular & Cellular Oncology · doi:10.4161/23723548.2014.970048 · Cited by 126
Hergovich, A., Kohler, R. S., Schmitz, D., Vichalkovski, A., Cornils, H., & Hemmings, B. A. (2009) · Current Biology · doi:10.1016/j.cub.2009.09.020 · Cited by 115
Angus, L., Moleirinho, S., Herron, L. R., Sinha, A., Zhang, X., Niestrata, M., Dholakia, K., Prystowsky, M. B., Harvey, K. F., Reynolds, P. A., et al. (2011) · Oncogene · doi:10.1038/onc.2011.224 · Cited by 109
Self-citationYu, J., Poulton, J., Huang, Y., & Deng, W. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001761 · Cited by 114
“role in restricting organ size by regulation of proliferation and apoptosis; reviewed by [1,2,3,4,5].”
BackgroundThe Hippo pathway regulates apical-domain size independently of its growth-control function
Genevet, A., Polesello, C., Blight, K., Robertson, F., Collinson, L., Pichaud, F., & Tapon, N. (2009) · Journal of Cell Science · doi:10.1242/jcs.041806 · Cited by 118
“…by The Company of Biologists 2009 doi:10.1242/jcs.041806 Jo ur na l o f C el l S ci en ce 2361Hippo signalling and cell polarity is composed of two kinases, Hippo (Hpo) and Warts (Wts), and of the scaffold proteins Salvador (Sav) and Mob as Tumour Suppressor (Mats) (Harvey and Tapon, 2007).”
BackgroundInfluentialSelf-citationDevelopment and morphogenesis of the Wolffian/epididymal duct, more twists and turns
Joseph, A., Yao, H. H., & Hinton, B. T. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2008.10.012 · Cited by 120
“Through these studies, the hippo kinase pathway was discovered and is essentially a growth suppressive pathway that functions by simultaneously inhibiting cell proliferation while promoting apoptosis (see recent reviews by (Buttitta and Edgar, 2007; Dong et al., 2007; Harvey and Tapon, 2007; Lecuit and Le Goff, 2007;…”
BackgroundLucifer's Labyrinth—Ten Years of Path Finding in Cell Death
Meier, P., & Vousden, K. H. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.11.016 · Cited by 113
“749 recently emerged as a ‘‘universal’’ growth-suppressive pathway that limits cell proliferation and survival to ensure proper organ size and tissue homeostasis ( Harvey and Tapon,2007 ).ThepathwayisbestunderstoodinDrosophila, where inactivation of the transcriptional coactivator Yorkie by the Hippo pathway shuts dow…”
BackgroundSpectrin regulates Hippo signaling by modulating cortical actomyosin activity
Deng, H., Wang, W., Yu, J., Zheng, Y., Qing, Y., & Pan, D. (2015) · eLife · doi:10.7554/elife.06567 · Cited by 113
“27 28 Introduction 29 30 The Hippo signaling pathway controls organ size in Drosophila through coordinated regulation 31 of cell growth, proliferation and apoptosis (Halder and Johnson, 2011; Harvey and Tapon, 2007; 32 Pan, 2007).”
Identification of Fat4 as a candidate tumor suppressor gene in breast cancers
Qi, C., Zhu, Y. T., Zhu, Y., & Zhu, Y. (2008) · International Journal of Cancer · doi:10.1002/ijc.23775 · Cited by 104
“Recently, Fat was found to be a component of Hippo signaling pathway, which plays an important role in controlling organ size.(7,8) Core components of Hippo signaling pathway include Salvador (SAV), warts (Wts), hippo and yorkie(YKI).”
BackgroundChan, S. W., Lim, C. J., Guo, F., Tan, I., Leung, T., & Hong, W. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.527598 · Cited by 103
WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ
Chan, S. W., Lim, C. J., Huang, C., Chong, Y. F., Gunaratne, H. J., Hogue, K. A., Blackstock, W. P., Harvey, K. F., & Hong, W. (2011) · Oncogene · doi:10.1038/onc.2010.438 · Cited by 102
“The Salvador/Warts/Hippo (Hippo) tumor suppressor pathway originally defined in Drosophila melanogaster is emerging as a conserved mechanism to regulate cell proliferation and organogenesis (Harvey and Tapon, 2007; Saucedo and Edgar, 2007; Zeng and Hong, 2008).”
BackgroundInfluentialSelf-citationFroldi, F., Ziosi, M., Garoia, F., Pession, A., Grzeschik, N. A., Bellosta, P., Strand, D., Richardson, H. E., Pession, A., & Grifoni, D. (2010) · BMC Biology · doi:10.1186/1741-7007-8-33 · Cited by 103
“How does Lgl depletion lead to dMyc upregulation in particular tissues? Recent analysis [47] has revealed that depletion of Lgl in the eye disc leads to deregulation of the Salvador-Warts-Hippo (SWH) tumour suppressor pathway, an evolutionarily conserved signalling pathway that controls organ size and prevents hyperpl…”
BackgroundFlow pattern-dependent endothelial cell responses through transcriptional regulation
Nakajima, H., & Mochizuki, N. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1364324 · Cited by 115
“The Hippo signaling pathway has emerged as a key negative regulator of tissue growth in Drosophila and mammalian systems.(96) The Hippo signaling pathway negatively regulates YAP by inducing nuclear export of YAP.”
BackgroundRegulation of organ size: Insights from the Drosophila Hippo signaling pathway
Kango‐Singh, M., & Singh, A. (2009) · Developmental Dynamics · doi:10.1002/dvdy.21996 · Cited by 101
Orr, B., & Compton, D. A. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00164 · Cited by 120
“In agreement, this pathway contains both oncogenes and tumor suppressor genes whose homologs have been identified in mammals (Overholtzer et al., 2006; Zender et al., 2006; Harvey and Tapon, 2007).”
BackgroundMeignin, C., Álvarez-García, I., Davis, I., & Palacios, I. M. (2007) · Current Biology · doi:10.1016/j.cub.2007.09.062 · Cited by 103
Targeting YAP and Hippo signaling pathway in liver cancer
Liu, A. M., Xu, Z., Chen, J., Poon, R. T. P., & Luk, J. M. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.499361 · Cited by 104
“Mutation resulted in neurofibromatosis type 2, a familial cancer syndrome that is characterized by nervous system tumors [104,105] MST1/2 Downregulation of the gene in soft tissue sarcoma with promoter hypermethylation [95].”
BackgroundHarvey, K. F., & Hariharan, I. K. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a011288 · Cited by 96
“1), also known as the SalvadorWarts-Hippo pathway, regulates tissue growth in a wide variety of organisms (Harvey and Tapon 2007; Grusche et al. 2010; Oh and Irvine 2010; Pan 2010; Halder and Johnson 2011; Zhao et al. 2011).”
BackgroundInfluentialSelf-citationThe lens epithelium in ocular health and disease
Martínez, G., & de Iongh, R. U. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.09.012 · Cited by 99
Gaffney, C. J., Oka, T., Mazack, V., Hilman, D., Gat, U., Muramatsu, T., Inazawa, J., Golden, A., Carey, D. J., Farooq, A., et al. (2012) · Gene · doi:10.1016/j.gene.2012.08.025 · Cited by 98
“The human YAP1 gene (NCBI GENE ID, 10413) is located on chromosome 11 at position q22 and the gene is frequently amplified in several human cancers including liver, breast, prostate and esophageal cancer (Sudol et al., 1995; Harvey and Tapon, 2007; Pan 2010).”
FOXP3 expression in tumor cells and implications for cancer progression
Triulzi, T., Tagliabue, E., Balsari, A., & Casalini, P. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24125 · Cited by 97
“, 2011), a molecule in the Hippo pathwaywith a role in regulating cell proliferation and apoptosis (Harvey and Tapon, 2007).”
BackgroundTeng, I.-W., Hou, P.-C., Lee, K.-D., Chu, P.-Y., Yeh, K.-T., Jin, V. X., Tseng, M.-J., Tsai, S.-J., Chang, Y.-S., Wu, C.-S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3418 · Cited by 98
“Abnormal SWH signaling pathway has been associated with tumorigenesis in both mammalian cells and Drosophila (26, 27), and RassF1A is a SWH pathway component controlling cellular proliferation, survival, anti-apoptosis, organ size and cell contact inhibition (20, 28).”
BackgroundInfluentialGrzeschik, N. A., Amin, N., Secombe, J., Brumby, A. M., & Richardson, H. E. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2007.08.025 · Cited by 105
“…discs and adult eyes appear different to other mutants that promote cell proliferation and inhibit apoptosis, such as those of the Hippo/Warts/Salvador/Mats pathway, which result in increased representation of the mutant clones at larval, pupal and adult stages (reviewed by Harvey and Tapon, 2007).”
BackgroundUsp7 regulates Hippo pathway through deubiquitinating the transcriptional coactivator Yorkie
Sun, X., Ding, Y., Zhan, M., Li, Y., Gao, D., Wang, G., Gao, Y., Li, Y., Wu, S., Lu, L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08334-7 · Cited by 99
Lai, C., Lin, C., Liao, W., Hour, T., Wang, H., & Chuu, C. (2019) · Cells · doi:10.3390/cells8040295 · Cited by 95
“Hippo-YAP pathway has been discovered to regulate cell proliferation and apoptosis [21,22], and is essential in the regulation of cancer development [23].”
BackgroundThe Hippo Tumor Suppressor Pathway (YAP/TAZ/TEAD/MST/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis
Zinatizadeh, M. R., Miri, S. R., Zarandi, P. K., Chalbatani, G. M., Rapôso, C., Mirzaei, H. R., Akbari, M. E., & Mahmoodzadeh, H. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2019.11.003 · Cited by 94
“phosphorylation pathway is the co-factor yes-associated protein (YAP) (dmYki) that participates in various activities (biological responses associated with different transcription factors).(26) The number of inputs of cell polarity regulators (Crumbs, Fat, Par 6/aPkc) and FERM domains upstream signal inducer proteins…”
BackgroundSherwood, V., Recino, A., Jeffries, A. C., Ward, A., & Chalmers, A. D. (2009) · Biochemical Journal · doi:10.1042/bj20091318 · Cited by 101
Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5
Ni, L., Li, S., Yu, J., Min, J., Brautigam, C. A., Tomchick, D. R., Pan, D., & Luo, X. (2013) · Structure · doi:10.1016/j.str.2013.07.008 · Cited by 94
“This tumor-suppressive pathway was first characterized in Drosophila through genetic screens for mutations that caused tissue overgrowth and was later shown to be conserved in mammals (Badouel et al., 2009; Edgar, 2006; Halder and Johnson, 2011; Harvey and Tapon, 2007; Harvey et al., 2013; Pan, 2010; Staley and Irvine…”
Interaction proteome of human Hippo signaling: modular control of the co‐activator YAP 1
Hauri, S., Wepf, A., van Drogen, A., Varjosalo, M., Tapon, N., Aebersold, R., & Gstaiger, M. (2013) · Molecular Systems Biology · doi:10.1002/msb.201304750 · Cited by 94
“These include the STE20 kinases MST1 and MST2 (orthologs of the Drosophila Hpo kinase) which bind to SAV1 (WW45), the AGC kinase LATS1 (Large tumor suppressor homolog 1) and its associated scaffold proteins MOB1A/B (Harvey & Tapon, 2007; Pan, 2007).”
Self-citationLi, W., Wang, L., Katoh, H., Liu, R., Zheng, P., & Liu, Y. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3268 · Cited by 105
“Genetic studies in Drosophila have established an important role for the Hippo pathway in regulation of cell proliferation and apoptosis (1-3).”
BackgroundMokhtari, R. B., Ashayeri, N., Baghaie, L., Sambi, M., Satari, K., Baluch, N., Bosykh, D. A., Szewczuk, M. R., & Chakraborty, S. (2023) · Cancers · doi:10.3390/cancers15133468 · Cited by 100
“The dysregulation of YAP and TAZ leads to tumor occurrence and contributes to cancer progression [5,69].”
BackgroundInfluentialMorinaka, A., Funato, Y., Uesugi, K., & Miki, H. (2011) · Oncogene · doi:10.1038/onc.2011.139 · Cited by 97
“The Hippo pathway appears to be conserved in mammals, and the human genes for several pathway components have been found to be mutated in cancers (O’Neill et al., 2005; Harvey and Tapon, 2007; Zeng and Hong, 2008).”
BackgroundInfluentialmicroRNA control of cell-cell signaling during development and disease
Hagen, J. W., & Lai, E. C. (2008) · Cell Cycle · doi:10.4161/cc.6447 · Cited by 94
The MST/Hippo Pathway and Cell Death: A Non-Canonical Affair
Fallahi, E., O’Driscoll, N., & Matallanas, D. (2016) · Genes · doi:10.3390/genes7060028 · Cited by 89
“Most of the components of the pathway are ubiquitously expressed, but in order to trigger cell death or cell cycle progression, the pathway activity is tightly regulated by complex molecular machinery [41].”
BackgroundThe Hippo pathway in chemotherapeutic drug resistance
Zhao, Y., & Yang, X. (2015) · International Journal of Cancer · doi:10.1002/ijc.29293 · Cited by 86
“When the Hippo pathway is activated in certain conditions such as increased cell–cell contact caused by high cell density, the upstream core component MST1/2 will be activated, which further phosphorylates and activates downstream kinase LATS1/2.4,9 The phosphorylated LATS can inhibit the transactivating functions of…”
BackgroundInfluentialDiep, C. H., Zucker, K. M., Hostetter, G., Watanabe, A., Hu, C., Munoz, R. M., Von Hoff, D. D., & Han, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032783 · Cited by 87
“The Hippo pathway regulates organ size by inhibiting cell proliferation and promotes cell apoptosis [2,3].”
BackgroundToloczko, A. D., Guo, F., Yuen, H., Wen, Q., Wood, S. A., Ong, Y. S., Chan, P. Y., Shaik, A. A., Gunaratne, J., Dunne, M. J., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3413 · Cited by 89
Kowalik, M. A., Saliba, C., Pibiri, M., Perra, A., Ledda-Columbano, G. M., Sarotto, I., Ghiso, E., Giordano, S., & Columbano, A. (2011) · Hepatology · doi:10.1002/hep.24289 · Cited by 86
Hippo pathway inhibition by blocking the YAP/TAZ–TEAD interface: a patent review
Crawford, J. J., Bronner, S. M., & Zbieg, J. R. (2018) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2018.1549226 · Cited by 88
Modularity and functional plasticity of scaffold proteins as p(l)acemakers in cell signaling
Pan, C. Q., Sudol, M., Sheetz, M. P., & Low, B. C. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.06.002 · Cited by 96
Zhang, X., Milton, C. C., Humbert, P. O., & Harvey, K. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4592 · Cited by 84
“breast cancers, whereas LATS1 nullizygous mice develop tumors (1);”
BackgroundSelf-citationPark, J., Kang, S. I., Lee, S., Zhang, X. F., Kim, M. S., Beers, L. F., Lim, D., Avruch, J., Kim, H., & Lee, S. B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.165506 · Cited by 90
FAT4 functions as a tumour suppressor in gastric cancer by modulating Wnt/β-catenin signalling
Cai, J., Feng, D., Hu, L., Chen, H., Yang, G., Cai, Q., Gao, C., & Wei, D. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.367 · Cited by 84
“Fat is a component of the Salvador–Warts–Hippo signalling pathway, which controls organ size by modulating cell growth, proliferation, and apoptosis (Harvey and Tapon, 2007; Berx and van Roy, 2009) and has a role in planar cell polarity (Qi et al, 2009).”
BackgroundEguizábal, C., Montserrat, N., Veiga, A., & Belmonte, J. C. I. (2013) · Seminars in Reproductive Medicine · doi:10.1055/s-0032-1331802 · Cited by 102
“20,21 In mammals, the capacity of regeneration following the dedifferentiation strategy is limited.”
The role of Hippo signal pathway in breast cancer metastasis
Wei, C., Wang, Y., & Li, X. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s157058 · Cited by 89
“The kinase cascade forms the core of the Hippo pathway and begins with MST1/2 phosphorylation of LATS1/2 to form a LATS1/2-MST1/2 complex, a process assisted by two scaffold proteins SAV1 and Mob1.(17) Activated LATS1/2 then goes on to phosphorylate downstream effectors YAP and TAZ.”
Activation mechanisms of the Hippo kinase signaling cascade
Bae, S. J., & Luo, X. (2018) · Bioscience Reports · doi:10.1042/bsr20171469 · Cited by 92
Mammalian Hippo signalling: a kinase network regulated by protein–protein interactions
Hergovich, A. (2012) · Biochemical Society Transactions · doi:10.1042/bst20110619 · Cited by 87
Relationship between growth arrest and autophagy in midgut programmed cell death in Drosophila
Denton, D., Chang, T.-K., Nicolson, S., Shravage, B., Simin, R., Baehrecke, E. H., & Kumar, S. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2012.43 · Cited by 81
“The highly conserved Salvador–Warts–Hippo pathway is a negative regulator of cell and tissue growth, and central to the pathway are the Hippo (Hpo) and Warts (Wts) kinases that act to inhibit the Yorkie transcription factor.(31) The Salvador–Warts–Hippo pathway has been shown to be required for correct removal of sali…”
BackgroundYap Controls Stem/Progenitor Cell Proliferation in the Mouse Postnatal Epidermis
Beverdam, A., Claxton, C., Zhang, X., James, G., Harvey, K. F., & Key, B. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.430 · Cited by 87
Self-citationHippo signalling in the G2/M cell cycle phase: Lessons learned from the yeast MEN and SIN pathways
Hergovich, A., & Hemmings, B. A. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.04.001 · Cited by 92
“In flies, members of the Ste20-like kinase, LATS/NDR, and MOB protein families have essential tumour suppressive roles by co-ordination cell growth, proliferation and death [16,21-23].”
BackgroundNuclear localization and pro‐apoptotic signaling of YAP2 require intact PDZ‐binding motif
Oka, T., & Sudol, M. (2009) · Genes to Cells · doi:10.1111/j.1365-2443.2009.01292.x · Cited by 82
Molecular Pathways: Hippo Signaling, a Critical Tumor Suppressor
Sebio, A., & Lenz, H. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0411 · Cited by 89
“The Salvador–Warts–Hippo pathway (known as Hippo pathway) was first discovered to be involved in controlling tissue growth in Drosophila melanogaster in 2002, and it has recently emerged as a critical tumor-suppressor network (1).”
BackgroundMechanisms of trophectoderm fate specification in preimplantation mouse development
Sasaki, H. (2010) · Development, Growth & Differentiation · doi:10.1111/j.1440-169x.2009.01158.x · Cited by 78
“The Hippo signaling pathway was originally identified as a tumor suppressor signaling pathway in Drosophila (see reviews and references therein, [Harvey & Tapon 2007; Pan 2007; Saucedo & Edgar 2007]).”
BackgroundDensham, R. M., O'Neill, E., Munro, J., König, I., Anderson, K., Kolch, W., & Olson, M. F. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00116-09 · Cited by 78
“Although MST kinases were identified because of their possible function as MAP4K that regulate SAPK pathways (17), much recent interest has been focused on the Drosophila melanogaster orthologue Hippo, which is a key regulator of cell growth, proliferation, and survival (31).”
BackgroundThe Hippo Pathway as a Driver of Select Human Cancers
Kulkarni, A., Chang, M. T., Vissers, J. H. A., Dey, A., & Harvey, K. F. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.04.004 · Cited by 81
Self-citationMammalian NDR/LATS protein kinases in hippo tumor suppressor signaling
Hergovich, A., & Hemmings, B. A. (2009) · BioFactors · doi:10.1002/biof.47 · Cited by 91
“M S T 1/ 2 O ve re xp re ss io n in ce ll s M S T 2 /L A TS 1 co o p e ra te in su p p re ss in g YA P -d ri ve n tr a n sf o rm a ti o n [2 5 ]”
BackgroundInfluentialWW domain interactions regulate the Hippo tumor suppressor pathway
Salah, Z., & Aqeilan, R. I. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.53 · Cited by 84
“Inactivation or mutations of some components of the pathway were identified in different types of cancer.(3,29,31) The Hippo pathway is composed of a kinase cascade core that includes MST1/2 serine/threonine kinase (ortholog of Hpo), WW45 scaffold protein (Sav), MOB (Mts) and LATS1/2 kinases (Wts)”
BackgroundThe Hippo signalling pathway maintains quiescence in Drosophila neural stem cells
Ding, R., Weynans, K., Bossing, T., Barros, C. S., & Berger, C. (2016) · Nature Communications · doi:10.1038/ncomms10510 · Cited by 84
YAP-Mediated Recruitment of YY1 and EZH2 Represses Transcription of Key Cell-Cycle Regulators
Hoxha, S., Shepard, A., Troutman, S. A., Diao, H., Doherty, J. R., Janiszewska, M., Witwicki, R. M., Pipkin, M. E., Ja, W. W., Kareta, M. S., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2415 · Cited by 80
McNeill, H., & Reginensi, A. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016060611 · Cited by 76
Cai, W., Lin, L., Hao, H., Zhang, S., Ma, F., Hong, X., Zhang, H., Liu, Q., Ye, G., Sun, G., et al. (2017) · Hepatology · doi:10.1002/hep.28911 · Cited by 76
“Inhibition of this pathway has been found to promote a wide range of cancers, especially HCC.(1,16,19,21,23,43-45) Many downstream targets of Hippo signaling, such as CTGF, CYR61, CCND1, and EDN1, have been identified(42,46,47); however, the exact downstream events and regulatory processes involved in this pathway rem…”
BackgroundInfluentialMolecular and Cellular Basis of Regeneration and Tissue Repair
Nakamura, T., Mito, T., Bando, T., Ohuchi, H., & Noji, S. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7432-0 · Cited by 75
The novel role of pyrvinium in cancer therapy
Momtazi‐borojeni, A. A., Abdollahi, E., Ghasemi, F., Caraglia, M., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26006 · Cited by 75
“Dysregulation of the Hippo pathway contributes to the development of cancers (Harvey & Tapon, 2007) such as tissue sarcomas and ovarian stromal cell tumors (St et al., 1999), non-small cell lung cancer, thyroid carcinoma (de Cristofaro et al., 2011; Zhou et al., 2011), and other cancers derived…”
BackgroundKohler, R. S., Schmitz, D., Cornils, H., Hemmings, B. A., & Hergovich, A. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00150-10 · Cited by 74
“NDR1(wt) and NDR1(1-380) coprecipitated hMOB2 (Fig.”
BackgroundMammalian NDR protein kinases: From regulation to a role in centrosome duplication
Hergovich, A., Cornils, H., & Hemmings, B. A. (2007) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2007.07.017 · Cited by 83
“Lats is also part of a novel signaling network in Drosophila, known as the Hpo/SWH pathway [23,24].”
BackgroundInfluentialRiquiqui and Minibrain are regulators of the Hippo pathway downstream of Dachsous
Degoutin, J. L., Milton, C. C., Yu, E., Tipping, M., Bosveld, F., Yang, L., Bellaïche, Y., Veraksa, A. N., & Harvey, K. F. (2013) · Nature Cell Biology · doi:10.1038/ncb2829 · Cited by 82
Self-citationGuo, Y. X., Cui, J. G., Ji, Z., Cheng, C., Zhang, K., Zhang, C., Chu, M., Zhao, Q., Yu, Z., Zhang, Y., et al. (2017) · Oncogene · doi:10.1038/onc.2017.240 · Cited by 74
Metadata
- Authors
- Harvey, K., & Tapon, N.
- Affiliations
- Peter MacCallum Cancer Centre (AU)
- Cancer Research UK (GB)
- Corresponding author
- Harvey, Kieran
- Venue
- Nature Reviews Cancer
- Published
- 2007-03
- Volume
- 7
- Issue
- 3
- Pages
- 182-191
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1567765448
- Cited by
- 628
- References
- 99
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 21 · 2023: 9 · 2022: 25 · 2021: 19 · 2020: 32 · 2019: 31 · 2018: 36 · 2017: 30 · 2016: 45 · 2015: 36 · 2014: 31 · 2013: 55 · 2012: 50
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- tumor suppression, tissue growth control, Drosophila melanogaster, carcinogenesis, evolutionary conservation, signaling networks, human cancer
- MeSH terms
- Hippo Kinases, Animals, Humans, Protein Kinases, Signal Transduction, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Drosophila Proteins, Intracellular Signaling Peptides and Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.